CMS to make 100% of claims data public
This article was originally published in The Gray Sheet
Researchers will soon get a gift from Medicare - they'll be able to order selections of data from up to 100% of claims. Steve Phurrough, CMS Coverage & Analysis Group director, told an audience at the Transcatheter Cardiovascular Therapeutics meeting Oct. 25 in Washington, D.C., that the database will include all Medicare claims data, beginning with 2005, including inpatient, outpatient, nursing home and durable medical equipment data. "You will be able as a researcher to say to us, 'I want to see all your data on MI, or kidney stones,' whatever it is that you want, and it will be 100% of our claims," he said. At present, researchers can only request a selection of about 5% of the data. Phurrough hopes that with expanded availability, mandated by the Medicare Modernization Act, CMS will see more clinical data that can be applied directly to the Medicare population...
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.